ACRONYM

ASPIRIN trial

A Phase III double-blind placebo-controlled Randomised Trial of Aspirin on Recurrence and Survival in Colon Cancer Patients

Laboratory technician using a telescope

Study information

Datacenter Department of Surgery
Leiden University Medical Center
Postzone K-6-R | P.O. Box 9600 | 2300 RC LEIDEN
The Netherlands
Tel +3171 526 3500 | Fax +3171 526 6744
E-mail datacenter@lumc.nl
Contact person: Jeffrey Braak

Rationale: Preclinical, epidemiologic and clinical evidence suggest that acetylsalicylic acid use may reduce overall cancer risk and mortality in colon cancer patients.

Objective: To investigate acetylsalicylic acid 80 mg po daily for 5 years as an adjuvant therapy in curatively operated, stage II and III colon cancer patients.

Study design: A phase III double-blind placebo-controlled randomised trial of adjuvant low-dose acetylsalicylic acid in colon cancer patients. The question will be addressed by means of two parallel studies in patients treated with or without adjuvant chemotherapy.

Trial website:

www.aspirinagainstcancer.org

 

Documents

Subscribe to our newsletter

Realisatie door Webfresh

Privacy Policy
© dccg.nl